Tereza Cervenka, MD

Education

• 1987-1991, BA Film, St. Olaf College, Northfield, Minnesota
• 1996-2000, MD, University of Minnesota Medical School
• 2000-2003, Internal Medicine Residency, University of Minnesota
• 2003-2007, Pulmonary/Critical Care Fellowship, University of Minnesota

Publications

Rocchini AP, Wilson RF, Marker P, Cervenka T. Metabolic and hemodynamic effects of graded intracoronary insulin infusion in normal and fat anesthetized dogs: a preliminary study. Hypertension; 27:354-359, 1996.

Rocchini AP, Marker P, Cervenka T. Time course of insulin resistance associated with feeding dogs a high-fat diet. American Journal of Physiology; 272: E147-54, 1997.

Miller JS, Cervenka T, Lund J, Okazaki IJ, Moss J. Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor. Journal of Immunology; 162: 7376-7382, 1999.

Zhang Y, Wroblewski M, Hertz M, Wendt C, Cervenka T, Nelsestuen G. Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid. Proteomics; 6(3):1001-1010, 2006.

Abstracts

Cervenka T, Nelsestuen G, Martinez M, Hertz M, Wendt C. Human Neutrophil Defensins 1-3: A biomarker of chronic lung allograft rejection. Oral presentation of abstract, Am J  Transplant  2004; S8(4):273.

Wendt C, Cervenka T, Zhang Y, Hertz M, Nelsestuen G. Biomarkers of chronic lung allograft rejection: A proteomic approach. Poster presentation of abstract, American Thoracic Society, 5/2005.

Cervenka T, Nelsestuen G. Savik K. Hertz M. Wendt C. Clara cell secretory protein is a biomarker for chronic lung allograft rejection due to early targeting of clara cells. Oral presentation of abstract, American Thoracic Society 5/2006.

Cervenka T, Nelsestuen G, Savik K. Hertz M. Wendt C. Human neutrophil defensins 1-3 predict the diagnosis of bronchiolitis obliterans syndrome in a prospective analysis of lung transplant patients. Oral presentation of abstract, American Thoracic Society 5/2006.

Last updated 10/10/2007